Pharmaceutical

FDA approves AbbVie’s VYALEV for advanced Parkinson’s treatment

The US FDA has approved AbbVie's VYALEV to treat motor fluctuations in adults with advanced Parkinson's disease (PD).

Oct 20, 2024 - 04:00
FDA approves AbbVie’s VYALEV for advanced Parkinson’s treatment
The US FDA has approved AbbVie's VYALEV to treat motor fluctuations in adults with advanced Parkinson's disease (PD).
Read the original article

Tags:

Previous Article

US Elections: how healthcare could look under a Harris or Trump administration

Next Article

Cambridge University and GSK sign immunology R&D collaboration

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Serum Institute of India wants government HPV contract

Serum Institute of India wants government HPV contract

Mar 4, 2024

Men taking valproate and their partners warned to use contraception by MHRA

Men taking valproate and their partners warned to use c...

Sep 8, 2024

Opinion: Home blood pressure machines are often wrong. The FDA must speak up

Opinion: Home blood pressure machines are often wrong. ...

Aug 15, 2023